199 related articles for article (PubMed ID: 37189343)
21. In vitro antiproliferative and cytotoxic activities of novel triphenyltin isoselenocyanate in human breast carcinoma cell lines MCF 7 and MDA-MB-231.
Hunakova L; Horvathova E; Matuskova M; Bobal P; Otevrel J; Brtko J
Med Oncol; 2022 May; 39(5):99. PubMed ID: 35599282
[TBL] [Abstract][Full Text] [Related]
22. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
23. New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation.
Gómez E; Galván-Hidalgo JM; Pérez-Cuéllar G; Huerta-Landa KA; González-Hernández A; Gómez-García O; Andrade-Pavón D; Ramírez-Apan T; Rodríguez Hernández KD; Hernández S; Cano-Sánchez P; Gómez-Velasco H
Bioinorg Chem Appl; 2023; 2023():7901843. PubMed ID: 37920233
[TBL] [Abstract][Full Text] [Related]
24. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
25. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
26. Novel diphenyltin(IV) complexes with carboxylato N-functionalized 2-quinolone ligands: Synthesis, characterization and in vitro anticancer studies.
Kasalović MP; Jelača S; Maksimović-Ivanić D; Lađarević J; Radovanović L; Božić B; Mijatović S; Pantelić NĐ; Kaluđerović GN
J Inorg Biochem; 2024 Jan; 250():112399. PubMed ID: 37890233
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.
Hadjikakou SK; Ozturk II; Xanthopoulou MN; Zachariadis PC; Zartilas S; Karkabounas S; Hadjiliadis N
J Inorg Biochem; 2008; 102(5-6):1007-15. PubMed ID: 18279959
[TBL] [Abstract][Full Text] [Related]
28.
Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
[TBL] [Abstract][Full Text] [Related]
29. Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach.
Silva A; Luís D; Santos S; Silva J; Mendo AS; Coito L; Silva TF; da Silva MF; Martins LM; Pombeiro AJ; Borralho PM; Rodrigues CM; Cabral MG; Videira PA; Monteiro C; Fernandes AR
Drug Metabol Drug Interact; 2013; 28(3):167-76. PubMed ID: 23800656
[TBL] [Abstract][Full Text] [Related]
30. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates.
Sirajuddin M; Ali S; McKee V; Akhtar N; Andleeb S; Wadood A
J Photochem Photobiol B; 2019 Aug; 197():111516. PubMed ID: 31170508
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
32. Heptacoordinate tin(IV) compounds derived from pyridine Schiff bases: synthesis, characterization, in vitro cytotoxicity, anti-inflammatory and antioxidant activity.
González A; Gómez E; Cortés-Lozada A; Hernández S; Ramírez-Apan T; Nieto-Camacho A
Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):5-15. PubMed ID: 19122310
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines.
Paunović MG; Matić MM; Obradović AD; Jevtić VV; Stojković DL; Ognjanović BI
Drug Dev Res; 2022 May; 83(3):688-698. PubMed ID: 34837232
[TBL] [Abstract][Full Text] [Related]
34. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines.
Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A
Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840
[TBL] [Abstract][Full Text] [Related]
35.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
36. Sulfonated Schiff base Sn(IV) complexes as potential anticancer agents.
Hazra S; Paul A; Sharma G; Koch B; da Silva MFCG; Pombeiro AJL
J Inorg Biochem; 2016 Sep; 162():83-95. PubMed ID: 27338202
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
[TBL] [Abstract][Full Text] [Related]
38. Triphenylstannyl((arylimino)methyl)benzoates with selective potency that induce G1 and G2/M cell cycle arrest and trigger apoptosis via ROS in human cervical cancer cells.
Basu Baul TS; Longkumer I; Duthie A; Singh P; Koch B; Guedes da Silva MFC
Dalton Trans; 2018 Feb; 47(6):1993-2008. PubMed ID: 29345708
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
